Open AccessAmulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial
Author(s) -
Roberto Galea,
Federico De Marco,
Nicolas Méneveau,
Adel Aminian,
Frédéric Anselme,
Christoph Gräni,
A Huber,
Emmanuel Teíger,
Xavier Iriart,
Flora Babongo Bosombo,
Dik Heg,
Anna Franzone,
Pascal Vranckx,
Urs Fischer,
Giovanni Pedrazzini,
Francesco Bedogni,
Lorenz Räber,
Marco Valgimigli
Publication year - 2021
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.121.057859
Subject(s) - medicine , percutaneous , thrombus , surgery , clinical endpoint , randomized controlled trial , atrial fibrillation , cardiology
No study has so far compared Amulet with the new Watchman FLX in terms of residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing percutaneous LAA closure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom